TODAY’S HEADLINES:
PowerVision pulls in $20M for intraocular lenses (VentureWire)
Heart device maker Mitralign raises $24M (release)
LifeOnKey, electronic medical-record IT firm, draws $5M of $10M round (Globes)
Merrion Pharma withdraws IPO filing (Edgar)
Hi-Tech Pharmacal acquires Midlothian Labs for
…
TODAY’S HEADLINES:
India’s Perfint, medical-device co., raises $3.5M (release)
Source MDx strikes Pfizer partnership to ID cancer, inflammation “fingerprints” (release)
Columbia River Resources acquires pharma RFID maker Traxxec (release)
India’s Perfint, medical-device co., raises $3.5M – Perfint, a Chennai, India-based …
TODAY’S HEADLINES:
Acorn Cardio raises $22M for heart-failure device (bizjournals.com)
Agile Therapeutics raises $5.6M for women’s health (release)
Polyheal draws $1M for wound healing (Globes)
MatrixBio receives seed funding for cancer diagnostics (release)
Pacira Pharma names David Stack as CEO
…
TODAY’S HEADLINES:
Gene-silencing developer Santaris raises €20M (PDF release)
Consumer-driven healthcare manager RedBrick Health prescribed $15M (release)
Cardiac Dimensions takes in $36M for heart-valve device (release)
TcLand Expressions gets €8.2M for biomarkers (PDF release)
TheraQuest Bio gets $3M for pain
…
Menlo Park, Calif.-based Cantimer, a stealthy developer of sensor technology with biomedical, biodefense and consumer applications, named Robin Stracey as its new CEO. The company’s release is here.
Cantimer’s Web site is still a stub, although it describes the company …
TODAY’S HEADLINES:
Specialty pharma Innocoll raises $30M for collagen technologies (release)
Immusol changes name to ItherX Pharma, names Jeffery McKelvy CEO (release)
Austin’s Santé Ventures raises $130M healthcare VC fund (release)
Belgium’s AlgoNomics, immunogenicity screener, names Philippe Stas as CEO
…
TODAY’S HEADLINES:
AcryMed, wound-healing specialist, sells itself to I-Flow for $25M (release)
Stent maker Devax pulls $85M IPO filing (Edgar)
Cempra Pharma gets $10M for anti-infective drugs (TechJournal South)
Genesis Genomics takes in C$312K for DNA-based diagnostics (GenomeWeb)
AcryMed, wound-healing …
TODAY’S HEADLINES:
Topical Botox maker Revance gets $43M, option to be acquired by Medicis (release)
Reva Medical draws $42M for resorbable stents (release)
AccentCare raises $8M for senior home-care services (VentureWire, sub req’d)
Light Dimensions aims for $6M for light-based
…
TODAY’S HEADLINES:
Fundamental Applied Biology pulls in $21M for proteins without cells (release)
Diagnostics maker Asuragen receives $19M (release)
Stroke-device maker Neurovasx raises $8.5M (release)
Cancer-vaccine maker ImmunoVaccine Tech buys Immunotope, seeks $15M (release)
Vascular imager CardioSpectra sells itself to
…
One of the constant but unavoidable challenges in trying to control diabetes is the frequent need to test blood-sugar levels by sticking a needle into a fingertip — a step that tells diabetics when they need a snack (to raise …
Featured companies: Adenosine Therapeutics, Allylix, Caprotec BioAnalytics, Equipois, F-Star, Insightec, MedNets.com, Renal Solutions, Transport Pharmaceuticals, VeriCare Management
UPDATED: Expanded items on Transport Pharmaceuticals, InSightec and VeriCare Management.
Transport Pharma aims for $35M for cold-sore treatment — Framingham, Mass.-based Transport Pharmaceuticals, …
Featured companies: American Aerogel, Clinicient, Frazier Healthcare Ventures, Genome Diagnostics, RadPharm, RainDance Technologies, Vivacta
UPDATED: Expanded items on Vitae, RadPharm, Vivacta and Genome Diagnostics. Intelligent Bio-Systems is now covered in a standalone item here.
Vitae Pharma takes in $15M for …
[NOTE: This is a life-sciences perspective piece by Robin Bellas, a partner at Morgenthaler Ventures. For previous perspective pieces, see here. --D.P.H.]
By ROBIN BELLAS
Does an ebb tide lower all boats? Not when the ship you’re sailing was …
Evalve, a Menlo Park, Calif., developer of minimally invasive heart-valve repair implants, raised $60 million in a fourth funding round.
Evalve’s device is designed to replace risky open-heart surgery for patients whose mitral valve, which regulates blood flow between the …
Featured companies: Bind Biosciences, Clarus Therapeutics, HealOr, HistroRx, Plasticell, SpinalMotion, Xenome, Yaupon Therapeutics
UPDATED: Expanded items on SpinalMotion and Plasticell. Previous items on Evalve and Excaliard have been expanded into standalone posts here and here.
Spinal-disc maker SpinalMotion arranges $14M …
Featured companies: Biospace Med, Carbylan BioSurgery, GVK BioSciences, IntraSafe Medical, InViragen, Medingo, ParadigmHealth, Precimed, SV Life Sciences
UPDATED: Expanded items on Carbylan, Medingo, and GVK Biosciences.
Carbylan raises $20M for arthritis, sinusitis drug implants — Palo Alto, Calif.-based Carbylan BioSurgery, …
Featured companies: Alere Medical, AorTx, BioMedical Innovations, Cavidi, Centice, Integrated BioPharma, Oxitech, Nastech
UPDATED: Expanded items on Centice, AorTx and Alere Medical.
Centice raises $11M for drug-safety technology — Centice, a Morrisville, N.C., developer of computer-sensor systems, raised $11 million …
Featured companies: BioVex, FullTurn Media, Humanetics, N Spine, Novitas Capital, Reliant Technologies, Symbios, Vaxart, Virtual Radiologic, Winston Laboratories, Zosano Pharma
EXPANDING ITEMS: Stay tuned.
Vaxart receives $3.3M for oral vaccines — San Francisco’s Vaxart, a biotech developing novel adenovirus-based vaccines, …
(UPDATED: See below.)
(NOTE: This item was originally published as part of today’s life-sciences briefing.)
EnteroMedics, a St. Paul, Minn., device maker working on a neuromodulation implant for treating obesity, slashed its expected IPO pricing by half, lowering …
(UPDATED: See below.)
Featured companies: Anaptys Biosciences, Arterial Remodeling Technologies, Cambria Biosciences, CaseNet, ChemoCentryx, Ensemble Discovery, MediQuest, Piedmont Pharmaceuticals, Raven Biotechnologies, Sensys Medical, Verus Pharmaceuticals, Xanodyne Pharmaceuticals
UPDATED: Expanded items on Anaptys, Arterial Remodeling, Raven Biotech, Sensys and MediQuest. …
